홈 » 전체 » 주식 예측 » Nerv Gen Pharma Corp. Common stock 예측

Nerv Gen Pharma Corp. Common stock 예측: 내일, 주간, 월간, 5년

업데이트됨: April 22 · 2026 at 07:03 UTC

From

▼ -3.00%Market Cap $282.60M · Technical analysis Bearish · Focus area Price + volatility

예측 요약

기간	예상 가격	과거	역사적인	통찰력
내일	$3.93 ▲ +1.24%	어제	$3.86 ▼ -0.52%	Tomorrow's NervGen Pharma Corp. Common stock (NGEN) setup is anchored to $3.88 and targets $3.93 (+1.24%). The near-term read is upside; watch $4.00 / $3.76 because daily realized volatility is about 6.38%.
Tomorrow's NervGen Pharma Corp. Common stock (NGEN) setup is anchored to $3.88 and targets $3.93 (+1.24%). The near-term read is upside; watch $4.00 / $3.76 because daily realized volatility is about 6.38%.
주간	$4.03 ▲ +3.85%	지난주	$3.82 ▼ -1.62%	The 7-day NervGen Pharma Corp. Common stock model moves from $3.82 to $4.03 (+3.85%). It gives upside momentum context for this stock, so breaks around $4.00 / $3.76 matter more than a single tick.
The 7-day NervGen Pharma Corp. Common stock model moves from $3.82 to $4.03 (+3.85%). It gives upside momentum context for this stock, so breaks around $4.00 / $3.76 matter more than a single tick.
월간	$4.20 ▲ +8.20%	지난달	$3.75 ▼ -3.44%	The 1-month NervGen Pharma Corp. Common stock target is $4.20 (+8.20%), compared with the live reference near $3.88. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month NervGen Pharma Corp. Common stock target is $4.20 (+8.20%), compared with the live reference near $3.88. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
연간	$4.45 ▲ +14.72%	지난해	$3.64 ▼ -6.18%	The 1-year NervGen Pharma Corp. Common stock scenario points to $4.45 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year NervGen Pharma Corp. Common stock scenario points to $4.45 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5년	$5.04 ▲ +30.00%	5년 전	$3.39 ▼ -12.60%	The 5-year NervGen Pharma Corp. Common stock view is $5.04 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year NervGen Pharma Corp. Common stock view is $5.04 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

내일$3.93▲ +1.24%

어제$3.86▼ -0.52%

Tomorrow's NervGen Pharma Corp. Common stock (NGEN) setup is anchored to $3.88 and targets $3.93 (+1.24%). The near-term read is upside; watch $4.00 / $3.76 because daily realized volatility is about 6.38%.

주간$4.03▲ +3.85%

지난주$3.82▼ -1.62%

The 7-day NervGen Pharma Corp. Common stock model moves from $3.82 to $4.03 (+3.85%). It gives upside momentum context for this stock, so breaks around $4.00 / $3.76 matter more than a single tick.

월간$4.20▲ +8.20%

지난달$3.75▼ -3.44%

The 1-month NervGen Pharma Corp. Common stock target is $4.20 (+8.20%), compared with the live reference near $3.88. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

연간$4.45▲ +14.72%

지난해$3.64▼ -6.18%

The 1-year NervGen Pharma Corp. Common stock scenario points to $4.45 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5년$5.04▲ +30.00%

5년 전$3.39▼ -12.60%

The 5-year NervGen Pharma Corp. Common stock view is $5.04 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

가격 차트

역사적인예측강세약세

기술적 분석

Neutral

강세

중립적

약세

주요 지표

지시자	값	신호
Price	$3.88	Mid
Daily Change	-3.00%	Below
Volatility Cap	20.0%	Mid
Confidence	64%	Above
Data Source	nasdaq-screener	Mid

과거 데이터

Current$3.88

Daily Change-3.00%

Market Cap$282.60M

Sourcenasdaq-screener

Current	$3.88	Daily Change	-3.00%
Market Cap	$282.60M	Source	nasdaq-screener

지지 및 저항 수준

$3.76지지 1

$3.88현재

$4.00저항 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

가격 이정표

주요 수준 및 역사적 맥락

Current$3.88Live reference price

Used as the anchor for generated forecast calculations.

Next Month$4.20Model projection+8.20%

Directional scenario based on capped drift.

예측 정확도

우리 모델의 성능

64%

방향성

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

우리의 알고리즘은 최신 가격 조치, 변동성 체제 및 지표 신호를 사용하여 매주 재보정됩니다. 정확도는 기간에 따라 다릅니다. 단기적인 모멘텀이 장기 예측보다 더 안정적입니다.

Short term

64%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

투자 시나리오

오늘 NGEN에 $1,000를 투자한다면

Bullish Scenario

$4.07

+5.00% from current

목표가격$4.07

대본Upside momentum

개연성56%

Base Scenario

$4.20

+8.20%

목표가격$4.20

대본Capped drift

개연성64%

Bearish Scenario

$3.69

-5.00% from current

목표가격$3.69

대본Volatility drawdown

개연성36%

기초: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

예측 요인

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 67/100

24H drift+1.24%

7D drift+3.85%

30D drift+8.20%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 65/100

1M outlook+8.20%

1Y outlook+14.72%

5Y outlook+30.00%

자주 묻는 질문

Q What is the NervGen Pharma Corp. Common stock (NGEN) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), NervGen Pharma Corp. Common stock is projected near $3.93 versus the current reference around $3.88. That implies a modeled move of +1.24% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for NGEN?

The weekly NervGen Pharma Corp. Common stock model points to $4.03, which maps to an expected drift of +3.85% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the NervGen Pharma Corp. Common stock 1-month and 1-year targets?

The NervGen Pharma Corp. Common stock 1-month target is $4.20 (+8.20%), while the 1-year target is $4.45 (+14.72%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the NervGen Pharma Corp. Common stock 5-year scenario differ from short-term rows?

The NervGen Pharma Corp. Common stock long-horizon scenario sits near $5.04 with a modeled change of +30.00%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are NGEN support and resistance zones right now?

For NervGen Pharma Corp. Common stock, nearest resistance is around $3.76, while nearest support is around $4.00. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the NervGen Pharma Corp. Common stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.